Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 6:61:102089.
doi: 10.1016/j.eclinm.2023.102089. eCollection 2023 Jul.

Why has the epidemiology of RSV changed during the COVID-19 pandemic?

Bahaa Abu-Raya  1   2 , Marina Viñeta Paramo  1   2 , Frederic Reicherz  1   2 , Pascal Michel Lavoie  1   2
Affiliations
Review

Why has the epidemiology of RSV changed during the COVID-19 pandemic?

Bahaa Abu-Raya et al. EClinicalMedicine. .

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has drastically perturbed the epidemiology of Respiratory Syncytial Virus (RSV) respiratory tract infections in children. The reasons for this are not clear. In this article, we review the current literature and critically discuss the different theories to explain why the epidemiology of RSV has changed during the COVID-19 pandemic. Proposed mechanisms include decreased viral immunity in vulnerable age groups caused by the prolonged lack of RSV circulation early in the pandemic, potential Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2)-induced immune dysregulation, viral interactions between SARS-CoV-2 and RSV, and modifications in health-seeking behaviors as well as heath systems factors. Research in viral genomics and phylogeny, and more robust immunology research is needed to guide RSV prevention and health care resource planning.

Keywords: COVID-19; Co-infection; RSV; Resurgence; Waning immunity.

PubMed Disclaimer

Conflict of interest statement

BA received honoraria for participation in live meetings from Sanofi Pasteur France and Canada related to pertussis (for BA) and RSV products, but not related to this study. PML received honoraria for participating in an Advisory Board meeting for Sanofi Canada, unrelated to this study. Other authors have no conflicts of interest to declare.

References

    1. Li Y., Wang X., Blau D.M., et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–2064. - PMC - PubMed
    1. Wildenbeest J.G., Billard M.N., Zuurbier R.P., et al. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study. Lancet Respir Med. 2023;11(4):341–353. - PMC - PubMed
    1. Dalziel S.R., Haskell L., O'Brien S., et al. Bronchiolitis. Lancet. 2022;400(10349):392–406. - PubMed
    1. Abu-Raya B., Reicherz F., Lavoie P.M. Correlates of protection against respiratory syncytial virus infection in infancy. Clin Rev Allergy Immunol. 2022;63(3):371–380. - PubMed
    1. Johannesen C.K., van Wijhe M., Tong S., et al. Age-specific estimates of respiratory syncytial virus-associated hospitalizations in 6 European countries: a time series analysis. J Infect Dis. 2022;226(Suppl 1):S29–S37. - PubMed

LinkOut - more resources